semaglutide vs orlistat Semaglutide Hype or Hope: Evidence-based Review in Diabesity Alli (Xenical) Vs Orlistat: Which

Both medications are effective for weight management, but choices depend on individual needs and goals

This new survey data shows that in the last six months, GLP-1 coverage has increased for both weight loss and diabetes

Healthcare providers should assess for: Persistent gastrointestinal symptoms that may indicate gallbladder disease Signs of pancreatitis (severe abdominal pain radiating to the back) Changes in vision or symptoms of diabetic retinopathy progression, especially in patients with pre-existing retinopathy Signs of dehydration or acute kidney injury with severe gastrointestinal symptoms Hypoglycemia when used with insulin or sulfonylureas (which may require dose reduction of these medications) Symptoms related to the boxed warning (thyroid tumors): neck mass, hoarseness, dysphagia, or dyspnea Patients should be aware that semaglutide is contraindicated during pregnancy and lactation, and women of childbearing potential should stop treatment approximately 2 months before a planned pregnancy

Requires careful sourcing from suppliers who provide third-party purity testing

Their purity is consistently high

Conclusion Evidence surrounding the role of GLP-1 therapies in CKD progression continues to grow as researchers examine how these medications influence kidney outcomes beyond glucose control